Literature DB >> 9724261

Differential 5-HT3 mediation of human gastrocolonic response and colonic peristaltic reflex.

E S Björnsson1, W D Chey, U Ladabaum, M L Woods, F G Hooper, C Owyang, W L Hasler.   

Abstract

Colonic motor function is modulated by extended and local neural reflexes involving unknown mediators. To test the role of serotonin (5-HT3) pathways, increases in colonic tone during antral distension and duodenal lipid perfusion (gastrocolonic responses) and changes in orad and caudad colonic tone in response to local colonic distension (peristaltic reflex) were measured after double-blind granisetron (10 microg/kg) or placebo infusion in healthy human volunteers. Antral distension evoked increases in colonic tone, which were blunted by granisetron (P < 0.05) without effects on antral compliance. Intraduodenal lipid perfusion also evoked increased colonic tone, which was reduced by granisetron (P < 0.05). In contrast, orad colonic contractions and caudad relaxations and contractions during colonic distension were unaffected by granisetron. In conclusion, 5-HT3 receptor antagonism blunts both the mechano- and chemoreceptor components of the human gastrocolonic response without altering antral compliance. In contrast, 5-HT3 pathways play no role in the ascending or descending components of the colonic peristaltic reflex. These findings demonstrate different roles for 5-HT3 receptors in the control of colonic motor function by the proximal gastrointestinal tract and by local neural reflexes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9724261     DOI: 10.1152/ajpgi.1998.275.3.G498

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  15 in total

1.  Comparison of ileoanal pouch and rectal function measured by barostat.

Authors:  J Steens; C Penning; W A Bemelman; G Griffioen; R A Van Hogezand; W J Meijerink; C B Lamers; A A Masclee
Journal:  Dig Dis Sci       Date:  2001-04       Impact factor: 3.199

2.  Intestinal gas distribution determines abdominal symptoms.

Authors:  H Harder; J Serra; F Azpiroz; M C Passos; S Aguadé; J-R Malagelada
Journal:  Gut       Date:  2003-12       Impact factor: 23.059

Review 3.  Serotonergic modulating drugs for functional gastrointestinal diseases.

Authors:  Robin Spiller
Journal:  Br J Clin Pharmacol       Date:  2002-07       Impact factor: 4.335

4.  Of actors, bolting horses, and drops in oceans!

Authors:  F Cremonini; M Camilleri
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

Review 5.  The clinical potential of ramosetron in the treatment of irritable bowel syndrome with diarrhea (IBS-D).

Authors:  Yang Won Min; Poong-Lyul Rhee
Journal:  Therap Adv Gastroenterol       Date:  2015-05       Impact factor: 4.409

6.  Ramosetron in irritable bowel syndrome with diarrhea: new hope or the same old story?

Authors:  Madhusudan Grover; Michael Camilleri
Journal:  Clin Gastroenterol Hepatol       Date:  2014-01-03       Impact factor: 11.382

7.  Effects of Clozapine on the Gut: Cross-Sectional Study of Delayed Gastric Emptying and Small and Large Intestinal Dysmotility.

Authors:  Susanna Every-Palmer; Stephen J Inns; Eve Grant; Pete M Ellis
Journal:  CNS Drugs       Date:  2019-01       Impact factor: 5.749

8.  Effect of meal ingestion on ileocolonic and colonic transit in health and irritable bowel syndrome.

Authors:  Annemie Deiteren; Michael Camilleri; Duane Burton; Sanna McKinzie; Archana Rao; Alan R Zinsmeister
Journal:  Dig Dis Sci       Date:  2010-02       Impact factor: 3.199

Review 9.  Role of visceral sensitivity in the pathophysiology of irritable bowel syndrome.

Authors:  M Delvaux
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

10.  Influence of gender, parity, and caloric load on gastrorectal response in healthy subjects: a barostat study.

Authors:  Cornelius E J Sloots; Richelle J F Felt-Bersma; Stephan G M Meuwissen; Ernst J Kuipers
Journal:  Dig Dis Sci       Date:  2003-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.